Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells

Infection and Immunity

Volumn 67, Issue 6, 1999, Pages 3014-3018

  Brunei, Laura Rosa ^a,d   Sabin, Elizabeth A ^a,e   Cheever, Allen W ^b   Kopf, Manfred A ^c   Pearce, Edward J ^a  

^a Animal Health Diagnostic Center   (United States)

^b BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e JAVMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE; PRAZIQUANTEL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EOSINOPHILIA; HELPER CELL; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION RESISTANCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE ACTIVATION; WORM INFECTION;

EID: 0032983440     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.6.3014-3018.1999     Document Type: Article

References (53)

1. Ben-Sasson, S. Z., G. Le Gros, D. H. Conrad, F. F. Finkelman, and W. E. Paul. 1990. Cross-linking Fc receptors stimulates splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc. Natl. Acad. Sci. USA 87:1421-1425.
2. Brindley, P., and A. Sher. 1987. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J. Immunol. 139:215-220.
3. Brindley, P., and A. Sher. 1990. Immunological involvement in the efficacy of praziquantel. Exp. Parasitol. 71:245-248.
4. Brito, P. D., J. Kazura, and A. Mahmoud. 1984. Host granulomatous response in Schistosomiasis mansoni. Antibody and cell-mediated damage of parasite eggs in vitro. J. Clin. Investig. 74:1715-1723.
5. Butterworth, A. E., R. F. Sturrock, V. Houba, A. A. F. Mahmoud, A. Sher, and P. H. Rees. 1975. Eosinophils as mediators of antibody dependent damage to schistosomula. Nature 256:727-729.
6. Cheever, A. W. 1970. Relative resistance of the eggs of the human schistosome to digestion in potassium hydroxide. Bull. WHO 43:601.
7. Coffman, R. L., B. W. P. Seymour, S. Haduk, J. Jackson, and D. Rennick. 1989. Antibody to IL-5 inhibits helminth-induced eosinophilia in mice. Science 245:308-310.
8. Cohn, R. G., M. Williams, A. Sher, and J. P. Caulfield. 1995. Schistosoma mansoni: characterization of an FcεR+ population of granule-containing splenocytes isolated from infected mice. Exp. Parasitol. 80:339-341.
9. Colley, D. G. 1972. Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp. Parasitol. 32:520-526.
10. Collins, P., S. Marleau, D. Griffiths-Johnson, P. Jose, and T. Williams. 1995. Cooperation between IL-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
11. Dean, D. A. 1983. Schistosoma and related genera: acquired resistance in mice. Exp. Parasitol. 55:1-104.
12. Doherty, T. M., R. Kastelein, S. Menon, S. Andrade, and R. L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151-7160.
13. Dunne, D. W., A. E. Butterworth, A. J. C. Fulford, H. C. Kariuki, J. G. Langley, J. H. Ouma, A. Capron, R. Pierce, and R. Sturrock. 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1483-1494.
14. Fallon, P., R. Cooper, A. Probert, and M. Doenhoff. 1992. Immune dependent chemotherapy of schistosomiasis. Parasitology 105:s41-48.
15. Florentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
16. Gordon, J., and S. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346:274-276.
17. Gryzch, J. M., E. J. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Hieny, F. A. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 144:1322-1327.
18. Hagan, P., H. Wilkin, U. Blumenthal, R. Hayes, and B. Greenwood. 1985. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7:625-632.
19. Harrison, R. A., Q. D. Bickle, and M. J. Doenhoff. 1982. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. IX. Evidence that the mechanisms which mediate resistance during early patent infections may lack immunological specificity. Parasitology 84:93-110.
20. James, S. L., and D. G. Colley. 1976. Eosinophil-mediated destruction of Schistosoma mansoni eggs. J. Reticuloendothel. Soc. 20:359-374.
21. Jones, R. E., F. D. Finkelman, R. B. Hester, and S. G. Keyes. 1994. Toxocara canis: failure to find IgE receptors on eosinophils from infected mice suggests that murine eosinophils do not kill helminth larvae by an IgE-dependent mechanism. Exp. Parasitol. 78:64-75.
22. Kopf, M., F. Brombacher, P. D. Hodgkin, A. J. Ramsay, E. A. Milbourne, W. J. Dai, K. S. Ovington, C. A. Behm, G. Kohler, I. G. Young, and K. I. Matthaei. 1996. IL-5 deficient mice have a developmental defect in CD5 + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24.
23. Liew, F. Y., Y. Li, A. Severn, S. Millott, J. Schmidt, M. Salter, and S. Moncada. 1991. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21:2489-2494.
24. Mahmoud, A., K. Warren, and R. G. Graham, Jr. 1975. Antieosinophilic serum and the kinetics of eosinophilia in schistosomiasis mansoni. J. Exp. Med. 142:560-574.
25. Mahmoud, A. A. F., K. S. Warren, and P. A. Peters. 1975. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by anti-eosinophil serum. J. Exp. Med. 142:805-513.
26. Mahmoud, A. A. F., and M. F. A. Wahab. 1990. Schistosomiasis, p. 458-473. In K. S. Warren and A. A. F. Mahmoud (ed.), Tropical and geographical medicine. McGraw Hill, New York, N.Y.
27. McLaren, D., and F. Ramalho-Pinto. 1979. Eosinophil-mediates killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement. J. Immunol. 123:1431-1438.
28. Moore, D., D. Grove, and K. Warren. 1977. The Schistosoma mansoni egg granuloma: quantitation of cell populations. J. Pathol. 121:41-50.
29. Olds, G., and A. Mahmoud. 1980. Role of host granulomatous responses in murine schistosomiasis: eosinophil mediated destruction of eggs. J. Clin. Investig. 66:1191-1199.
30. Oswald, I. P., R. G. Gazzinelli, A. Sher, and S. L. James. 1992. IL-10 synergizes with IL-4 and TGF-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3582.
31. Paul, W. E., R. A. Seder, and M. Plaut. 1993. Lymphokine and cytokine production by FœRI+ cells. Adv. Immunol. 53:1-29.
32. Pearce, E. J., P. Caspar, J. M. Gryzch, F. A. Lewis, and A. Sher. 1991. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a helminth, Schistosoma mansoni. J. Exp. Med. 173:159-165.
33. Phillips, S. M., and P. J. Lammie. 1986. Immunopathology of granuloma formation and fibrosis in schistosomiasis. Parasitol. Today 2:296-302.
34. Rihet, P., D. E. Demeure, A. Bourgois, A. Prata, and A. J. Dessein. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:2679-2686.
35. Rosa Brunet, L., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-cx mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777-785.
36. Rosa Brunet, L., and E. J. Pearce. Unpublished data.
37. Sabah, A., C. Fletcher, G. Webbe, and M. Doenhoff. 1985. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Exp. Parasitol. 60:348-354.
38. Sabin, E. A., M. A. Kopf, and E. J. Pearce. 1996. Schistosoma mansoni egg induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184:1871-1878.
39. Sabin, E. A., and E. J. Pearce. 1995. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155:4844-4853.
40. Sanderson, C., H. Campbell, and I. Young. 1988. Molecular and cellular biology of eosinophil differentiation factor (IL-5) and its effect on human and mouse B cells. Immunol. Rev. 102:29-50.
41. Seder, R. A., M. Plaut, S. Barbier, J. Urban, F. D. Finkelman, and W. E. Paul. 1991. Purified FcεR+ bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin. J. Immunol. 147:903-909.
42. Sher, A., R. L. Coffman, S. Hieny, and A. W. Cheever. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:3911-3916.
43. Sher, A., R. L. Coffman, S. Hieny, P. Scott, and A. W. Cheever. 1990. Inlerleukin 5 (IL-5) is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. USA 87:61-66.
44. Sher, A., D. Florentino, P. Casper, E. J. Pearce, and T. R. Mosmann. 1991. Production of IL-10 by CD44 T lymphocytes correlates with down regulation of Th1 cytokine synthesis. J. Immunol. 147:2713-2718.
45. Sher, A., P. Mackenzie, and S. R. Smithers. 1974. Decreased recovery of invading parasites from the lungs as a parameter of acquired immunity to schistosomiasis in the laboratory mouse. J. Infect. Dis. 130:626-633.
46. Sher, A., S. R. Smithers, and P. Mackenzie. 1975. Passive transfer of acquired resistance to Schistosoma mansoni in laboratory mice. Parasitology 70:347-357.
47. Smithers, D. V., and R. J. Terry. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitology 55:695-700.
48. Smithers, S., and R. Terry. 1969. Immunity in schistosomiasis. Ann. N. Y. Acad. Sci. 160:826-840.
49. Tepper, R., R. Coffman, and P. Leder. 1992. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548-551.
50. Vasconcelos, J. P., and E. J. Pearce. 1996. Type 1 CDS+ T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157: 3046-3053.
51. Vella, A. T., and E. J. Pearce. 1992. CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148:2283-2290.
52. Williams, M. E., M. C. Kullberg, S. Barbieri, P. Caspar, J. A. Berzofsky, R. A. Seder, and A. Sher. 1993. Fc epsilon receptor-positive cells are a major source of antigen-induced interleukin-4 in spleens of mice infected with Schistosoma mansoni. Eur. J. Immunol. 23:1910-1916.
53. Wilson, R. A., P. S. Coulson, and S. M. McHugh. 1983. A significant part of the concomitant immunity of mice to Schistosoma mansoni is the consequence of a leaky hepatic portal system not immune killing. Parasite Immunol. 5:595-605.